Novartis Pharmaceuticals Australia Pty Ltd - Notification - N98692

Applicant(s)

  • Novartis Pharmaceuticals Australia Pty Ltd

Notification number(s)

  • N98692

Summary

Novartis will supply a range of services under its Pathway Program on condition that patients purchase Glivec of Tasigna prescribed by their treating physician through APG Cooleman Pty Ltd (APG).

Notifications

Document title Date

ACCC correspondence

Document title Date